동향
동향 내용
Alternative splicing as a biomarker and potential target for drug discovery.
분류 drug discovery 조회 1491
발행년도 2015 등록일 2015-10-10
출처 Acta Pharmacol Sin (바로가기)
Alternative splicing is a key process of multi-exonic gene expression during pre-mRNA maturation. In this process, particular exons of a gene will be included within or excluded from the final matured mRNA, and the resulting transcripts generate diverse protein isoforms. Recent evidence demonstrates that approximately 95% of human genes with multiple exons undergo alternative splicing during pre-mRNA maturation.
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Approaches of targeting Rho GTPases in cancer drug discovery.
다음글다음글 Development of nanotoxicology: implications for drug delivery and medical devices.